New Product Launch: Influenza A virus subtype H5N1 Controls

We are proud to introduce our latest innovation — recombinant Influenza A virus subtype H5N1 Controls, developed to provide high-quality, reliable tools for both research and diagnostic applications.

🔬 Product Highlights:

  • Two recombinant H5N1 strains available:
    • NCBI Reference Strain (NC_007362.1) – carrying the HA (segment 4) of the reference H5N1 strain
    • Clade 2.3.4.4b Consensus Strain – carrying consensus sequences of segments 4 (HA), 7, and 8 of the most recent circulating H5N1 Clade, along with the NA (segment 6) gene with the H275Y drug resistance mutation
  • Standard Titer: 500,000 copies/ml
  • Pack Size: 1.0 ml
  • Storage: Below -70 °C

✨ These controls are designed to support influenza virus monitoring, antiviral resistance research, and diagnostic assay development, ensuring accuracy, reproducibility, and confidence in your results.

📩 For more details or to place your order, please contact us at info@anchormolecular.com

Share:

Comments are closed

2025 Press Releases

New Product Launch: Influenza A virus subtype ...

September 24, 2025 Comments Off on New Product Launch: Influenza A virus subtype H5N1 Controls

New Product Launch: POLE-POLD1 Mutation Controls

September 24, 2025 Comments Off on New Product Launch: POLE-POLD1 Mutation Controls

New Product Launch: BCR-ABL1 Control Panels

September 24, 2025 Comments Off on New Product Launch: BCR-ABL1 Control Panels

Related Articles

View All Articles
Press Releases

New Product Launch: BCR-ABL1 Control Panels

We’re excited to announce the launch of our BCR-ABL1 Control Panels, designed to support laboratories and researchers in monitoring the performance of quantitative detection of BCR-ABL1 translocation mRNA transcripts. These panels provide high-quality reference material for e14a2 (p210), e13a2 (p210), e1a2 (p190) transcripts, and the ABL1 endogenous control mRNA transcript,...
by yabin2017 213 Comments Off on New Product Launch: BCR-ABL1 Control Panels
Press Releases

New Product Launch: POLE-POLD1 Mutation Controls

We are excited to announce the launch of our POLE-POLD1 Mutation Controls, designed to support researchers and clinicians in advancing cancer diagnostics and immunotherapy research. About POLE-POLD1 mutations:POLE-POLD1 mutations affect DNA replication and proofreading functions, leading to increased mutational burden and conditions such as Polymerase Proofreading-Associated Polyposis (PPAP) syndrome. While...
by yabin2017 135 Comments Off on New Product Launch: POLE-POLD1 Mutation Controls